Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia

QR Code

Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia

Saved in:

Bibliographic Details
Main Authors:	Sarah E. Smith, MD, Leah A. Swanson, MD, Alex Wonnaparhown, MD, David J. DiCaudo, MD, Steven A. Nelson, MD, Michael Kasperkiewicz, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	JAAD Case Reports
Subjects:	atopic dermatitis autoimmune blistering disorder dupilumab eosinophilia immunobullous disease pemphigus herpetiformis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512625002528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pemphigus Herpetiformis in Childhood: Clinical Case
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01)

Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01)

Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review
by: Boonpethkaew S, et al.
Published: (2025-07-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

CLINICAL AND HISTOLOGICAL COMPARISON OF CELIAC DISEASE AND DERMATITIS HERPETIFORMIS IN MALE PATIENTS: A TEN-YEAR RETROSPECTIVE STUDY
by: Lorete Maria da Silva KOTZE, et al.
Published: (2025-07-01)

Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01)

The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)

Acute generalized exanthematous pustulosis triggered by dupilumab
by: Caterina Mariarosaria Giorgio, et al.
Published: (2025-07-01)

Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China
by: Yue Xu, et al.
Published: (2025-07-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Modern Possibilities of Usage Dupilumab in Children
by: Anna A. Kosova, et al.
Published: (2024-12-01)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01)

New Opportunities of Dupilumab in Achieving Disease Control in Preschool Age Patients with Atopic Dermatitis: Clinical Case
by: Julia G. Levina, et al.
Published: (2024-09-01)

Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01)

Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis
by: Paulina Stepinska, et al.
Published: (2025-12-01)

Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-09-01)

Alopecia Areata Associated with Dupilumab: National Database Study
by: Tarun Sontam, et al.
Published: (2025-07-01)

A clinical case of atopic dermatitis with a rapid positive effect from the use of a genetically engineered biological drug in a teenager
by: E. V. Churyukina, et al.
Published: (2024-05-01)

Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01)

Experimental models of dermatological diseases
by: O. N. Sergeeva, et al.
Published: (2019-10-01)

[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]
by: Paolo Gisondi, et al.
Published: (2025-05-01)

Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review
by: Cristina Guerriero, et al.
Published: (2025-07-01)

Evaluation of the levels of interleukins IL-4, IL-13, IL-5, IL-10 and IL-33 in atopic dermatitis patients with and without dupilumab therapy
by: Jarmila Čelakovská, et al.
Published: (2025-07-01)

Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in Japan
by: Hidehisa Saeki, et al.
Published: (2025-07-01)

A newly identified pathology of episodic angioedema with hypereosinophilia (Gleich syndrome) revealed by multiomics analysis
by: Tatsuya Koreeda, MS, et al.
Published: (2025-08-01)

Dupilumab in children and adolescents with atopic dermatitis, a 52-week real-life experience: first report in Colombia
by: Daniela Meléndrez Vásquez, et al.
Published: (2024-10-01)

Successful treatment of scleromyxedema with dupilumab: A case report
by: Abdulelah Alghamdi, MBBS, et al.
Published: (2025-09-01)

Brown patches and erosions with an erythematous base
by: Madisen A. Swallow, MS, et al.
Published: (2025-08-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Successful management of Netherton syndrome using IVIG and dupilumab: A case report
by: Reshale Johar, MD, et al.
Published: (2025-08-01)

Rituximab in pemphigus and pemphigoid patients: Treatment outcomes and safety profile - A 6-year tertiary center study
by: Sivakanth Gopakumar, et al.
Published: (2025-07-01)

Results of Combined Pathogenetic Therapy in Netherton Syndrome: Clinical Case
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01)

Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01)

Suspensión de dupilumab en dermatitis atópica. ¿es una opción la suspensión? Seguimiento de 12 casos
by: Mirian Casas-Vargas, et al.
Published: (2024-10-01)

Two pediatric cases of alopecia universalis with concomitant atopic dermatitis successfully treated with baricitinib
by: Shoichiro Muratani, MD, et al.
Published: (2025-09-01)

Characteristics and management of pediatric pemphigus vulgaris
by: LIANG Wenhui, CHEN Yuting, DAN Hongxia
Published: (2025-07-01)

Allergic-related skin diseases: Global disease burden from 1990 to 2021 and future trends
by: Xiao Tang, MD, et al.
Published: (2025-07-01)

A 10-Year Observational Study on Treatment Approaches in Pemphigus and Pemphigoid
by: Cristiana Palmela Pereira, et al.
Published: (2025-01-01)